Organogenesis Overview

  • Founded
  • 1985
Founded
  • Status
  • Public
  • Employees
  • 900
Employees
  • Stock Symbol
  • ORGO
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $9.50
  • (As of Friday Closing)

Organogenesis General Information

Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Contact Information

Website
www.organogenesis.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 85 Dan Road
  • Canton, MA 02021
  • United States
+1 (781) 000-0000

Organogenesis Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Organogenesis Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.50 $9.49 $2.47 - $10.51 $1.21B 128M 601K -$0.05

Organogenesis Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 479,659 576,879 59,694 384,282
Revenue 306,136 260,981 193,449 198,508
EBITDA 11,495 (21,877) (46,980) (912)
Net Income (4,943) (40,454) (64,831) (8,388)
Total Assets 246,428 220,687 163,678 148,722
Total Debt 114,731 100,606 59,261 102,335
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Organogenesis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Organogenesis‘s full profile, request access.

Request a free trial

Organogenesis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercializa
Biotechnology
Canton, MA
900 As of 2020
00000
00000000 00000

0000000

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 000000000
San Diego, CA
00 As of 0000
00000
000000 - 000 00000

00000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
South San Francisco, CA
00 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Organogenesis Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViaCyte Venture Capital-Backed San Diego, CA 00 00000 000000 - 000 00000
00000000 Venture Capital-Backed South San Francisco, CA 00 00000 0000000000 00000
000000000 Corporation Melbourne, Australia 000 00000 000000000 00000
00000000 Venture Capital-Backed Durham, NC 000 00000 000000000 - 00000
00000000 Formerly VC-backed San Diego, CA 00 000.00 000000000 000.00
You’re viewing 5 of 23 competitors. Get the full list »

Organogenesis Executive Team (8)

Name Title Board Seat Contact Info
Gary Gillheeney Sr. Chief Executive Officer & Board Member
Henry Hagopian Chief Financial Officer, Finance & Treasurer, Finance
Patrick Bilbo Chief Operating Officer, Operations
Brian Grow Executive
You’re viewing 4 of 8 executive team members. Get the full list »

Organogenesis Board Members (6)

Name Representing Role Since
0000 0000 Organogenesis Chairman & Board Member 000 0000
0000 0000000000 00. Organogenesis Chief Executive Officer & Board Member 000 0000
000000 00000000 Self Board Member 000 0000
00000 000000 Organogenesis Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Organogenesis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Organogenesis Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000 17-Sep-2020 000000000000000000 0000 Surgical Devices 0000 0000000000 00.
000000 0000000000 10-Dec-2018 000000000000000000 Holding Companies 0000 0000000000 00.
000000 0000000 28-Mar-2017 000000000000000000 Surgical Devices 0000 0000000000 00.
00000 (0000000000 17-Jan-2014 000000000000000000 00000 Pharmaceuticals
NanoMatrix 25-Feb-2008 Merger/Acquisition Biotechnology 00000 000000
To view Organogenesis’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Organogenesis Subsidiaries (2)

Company Name Industry Location Founded
NuTech Medical Surgical Devices Birmingham, AL 1994
000 00000000000 Surgical Devices Largo, FL
To view Organogenesis’s complete subsidiaries history, request access »